Tue, Jul 22, 2014, 9:26 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Insmed Incorporated Message Board

  • risingedge77 risingedge77 Jan 14, 2013 11:58 AM Flag

    Insiders have been buying

    WSJ - Market Watch:

    The President and CEO of Insmed Incorporated bought almost 11,000 shares of the stock on January 9th at $6.90 per share, roughly doubling his direct holdings. Insmed is a $210 million market cap biotech company (almost 200,000 shares have been traded per day in average for the last three months, so there is over $1 million in daily dollar volume). As a development stage company Insmed is not expected to be profitable in 2013; however, the stock has roughly doubled in the last year. We wouldn't take any action but the CEO's purchase is noted in case there are any further developments at the company.

    Sentiment: Buy

 
INSM
17.70-0.04(-0.23%)Jul 22 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.